TriMas Co. (NASDAQ:TRS) Shares Sold by Two Sigma Advisers LP

Two Sigma Advisers LP cut its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 12.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 130,500 shares of the industrial products company's stock after selling 19,200 shares during the period. Two Sigma Advisers LP owned about 0.32% of TriMas worth $3,209,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of TRS. Bank of America Corp DE lifted its position in TriMas by 127.3% during the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock valued at $86,400,000 after purchasing an additional 1,967,738 shares in the last quarter. Bellecapital International Ltd. bought a new stake in TriMas during the fourth quarter valued at about $29,160,000. Raymond James Financial Inc. bought a new stake in TriMas during the fourth quarter valued at about $6,698,000. Kennedy Capital Management LLC raised its holdings in TriMas by 94.8% during the fourth quarter. Kennedy Capital Management LLC now owns 485,721 shares of the industrial products company's stock valued at $11,944,000 after acquiring an additional 236,346 shares during the period. Finally, Advisory Research Inc. raised its holdings in TriMas by 41.2% during the fourth quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock valued at $18,543,000 after acquiring an additional 220,000 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

TriMas Trading Down 1.0%

Shares of NASDAQ:TRS traded down $0.27 during trading hours on Friday, hitting $26.35. 331,894 shares of the company's stock traded hands, compared to its average volume of 334,550. TriMas Co. has a 1 year low of $19.33 and a 1 year high of $28.51. The business has a fifty day moving average price of $23.20 and a 200-day moving average price of $24.01. The firm has a market capitalization of $1.07 billion, a P/E ratio of 41.17 and a beta of 0.58. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.

TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.03. The firm had revenue of $241.67 million during the quarter, compared to analyst estimates of $235.41 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. TriMas's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.37 earnings per share. Equities analysts expect that TriMas Co. will post 1.69 earnings per share for the current year.

TriMas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date was Tuesday, May 6th. TriMas's dividend payout ratio (DPR) is 20.78%.

Insider Buying and Selling

In other TriMas news, Director Shawn Sedaghat purchased 72,937 shares of TriMas stock in a transaction dated Thursday, May 22nd. The shares were acquired at an average cost of $26.16 per share, with a total value of $1,908,031.92. Following the completion of the transaction, the director now owns 1,883,758 shares in the company, valued at approximately $49,279,109.28. This trade represents a 4.03% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Scott A. Mell sold 2,218 shares of the company's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total value of $49,993.72. Following the transaction, the chief financial officer now directly owns 26,288 shares in the company, valued at approximately $592,531.52. The trade was a 7.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired 1,770,195 shares of company stock valued at $43,736,754 over the last 90 days. Corporate insiders own 14.20% of the company's stock.

Wall Street Analyst Weigh In

TRS has been the topic of a number of recent analyst reports. Wall Street Zen cut TriMas from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. BWS Financial reiterated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research report on Wednesday, April 30th.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.